1. Home
  2. WRAP vs GNLX Comparison

WRAP vs GNLX Comparison

Compare WRAP & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WRAP
  • GNLX
  • Stock Information
  • Founded
  • WRAP 2016
  • GNLX 2001
  • Country
  • WRAP United States
  • GNLX United States
  • Employees
  • WRAP N/A
  • GNLX 25
  • Industry
  • WRAP Ordnance And Accessories
  • GNLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • WRAP Industrials
  • GNLX Health Care
  • Exchange
  • WRAP Nasdaq
  • GNLX Nasdaq
  • Market Cap
  • WRAP 91.2M
  • GNLX 184.4M
  • IPO Year
  • WRAP N/A
  • GNLX 2023
  • Fundamental
  • Price
  • WRAP $2.13
  • GNLX $5.34
  • Analyst Decision
  • WRAP
  • GNLX Strong Buy
  • Analyst Count
  • WRAP 0
  • GNLX 4
  • Target Price
  • WRAP N/A
  • GNLX $18.25
  • AVG Volume (30 Days)
  • WRAP 152.8K
  • GNLX 396.9K
  • Earning Date
  • WRAP 11-14-2024
  • GNLX 03-31-2025
  • Dividend Yield
  • WRAP N/A
  • GNLX N/A
  • EPS Growth
  • WRAP N/A
  • GNLX N/A
  • EPS
  • WRAP N/A
  • GNLX N/A
  • Revenue
  • WRAP $4,231,000.00
  • GNLX $8,000.00
  • Revenue This Year
  • WRAP N/A
  • GNLX N/A
  • Revenue Next Year
  • WRAP N/A
  • GNLX N/A
  • P/E Ratio
  • WRAP N/A
  • GNLX N/A
  • Revenue Growth
  • WRAP N/A
  • GNLX N/A
  • 52 Week Low
  • WRAP $1.21
  • GNLX $1.60
  • 52 Week High
  • WRAP $4.29
  • GNLX $8.67
  • Technical
  • Relative Strength Index (RSI)
  • WRAP 57.39
  • GNLX 72.84
  • Support Level
  • WRAP $1.92
  • GNLX $4.10
  • Resistance Level
  • WRAP $2.07
  • GNLX $5.89
  • Average True Range (ATR)
  • WRAP 0.11
  • GNLX 0.54
  • MACD
  • WRAP -0.00
  • GNLX 0.14
  • Stochastic Oscillator
  • WRAP 87.50
  • GNLX 79.70

About WRAP Wrap Technologies Inc.

Wrap Technologies Inc offers public safety technologies and services. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

Share on Social Networks: